-

Paragonix Technologies Presenting Expansive Organ Transplant Research at the International Society of Heart and Lung Transplantation 2023 Annual Meeting

Clinical Evidence for Paragonix medical devices presented in multiple seminars and posters at Denver’s ISHLT 2023 Annual Meeting

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Paragonix Technologies, Inc., a leading organ transplant company, is dedicated to advancing the science of modern transplantation by conducting novel research powered by the GUARDIAN registries - the largest clinical databases specifically focused on the preservation of donor organs during transport. Participating investigators will present research on a variety of factors - including organ preservation, transportation, and characteristics of both donors and recipients - at the 2023 International Society for Heart and Lung Transplantation 43rd Annual Meeting and Scientific Sessions, held in late April at the Colorado Conference Center in Denver, CO.

“Together with our clinical investigators, we have built the largest global thoracic registry dedicated to the scientific study of organ preservation. We are indebted to our clinical investigators who share our vision and are questioning old practices in organ transport,” said Dr. Lisa Anderson, President and CEO of Paragonix. “The ISHLT Annual Meeting is one of our industry's premier scientific gatherings and it is an honor to be able to share our tremendous research efforts with its attendees.”

Clinical investigators will be sharing data related to Paragonix technology in six oral presentations, eight mini-oral presentations, and multiple posters during the event, including:

Oral Presentations

Mini-Oral Presentations

Poster Presentations

Additionally, Paragonix will be hosting two Industry Symposia on Advanced Organ Preservation research at the conference. On Thursday, April 20th, at 11:30 AM in rooms 501 – 504, Paragonix will be presenting a symposium titled Beyond Limits: Harnessing Advanced Preservation to Enhance Donor Lung Procurement. The event will feature leading experts in the field as they discuss the latest breakthroughs and innovations in preserving lung viability for transplantation.

On Friday, April 21st, at 11:30 AM in rooms 501 – 504, Paragonix will be hosting a heart symposium titled Resetting the Standard: Impact of Advanced Heart Preservation on Program Growth. The event will host top industry experts who will delve into the science behind Paragonix's innovative solutions, discuss their use of advanced organ preservation, and present the impact of advanced preservation on patient outcomes. Both of these events are Non-CME industry events presented by Paragonix Technologies.

To visit the Paragonix Technologies exhibit and meet members of their team at ISHLT, visit booth #301. For more information about Paragonix, visit www.paragonix.com.

About Paragonix Technologies

Paragonix Technologies is a leading developer, manufacturer, and service provider in the organ transplant industry, establishing a novel approach to preservation that represents a significant improvement over the traditional standard of care.

Paragonix Advanced Organ Preservation devices combine clinically-proven, stable cooling techniques with digital tracking and monitoring technologies to provide clinicians complete control and oversight throughout the donor organ journey. The clinical impact of Paragonix preservation technology is reinforced by the GUARDIAN clinical registries, the largest database of organ preservation data in the world that analyzes post-transplant outcomes in transplant recipients. For more information, visit www.paragonix.com.

Follow us on Twitter: @ParagonixSherpa
Connect with us on LinkedIn: Paragonix Technologies
Like Us on Facebook: Paragonix SherpaPak

Contacts

Media:
Adam Lafreniere, Director, Marketing Operations
marketing@paragonixtechnologies.com
L-425, Rev 0

Industry:

Paragonix Technologies, Inc.

Release Versions
English

Contacts

Media:
Adam Lafreniere, Director, Marketing Operations
marketing@paragonixtechnologies.com
L-425, Rev 0

More News From Paragonix Technologies, Inc.

Paragonix to Spotlight Breakthrough Research in Solid Organ Transplantation at the 2025 World Transplant Congress

WALTHAM, Mass.--(BUSINESS WIRE)--Paragonix Technologies, Inc., a pioneer in advanced organ transplant preservation and surgical services, is proud to announce an impactful presence at the upcoming World Transplant Congress (WTC) 2025, taking place August 2–6 at the Moscone Center in San Francisco, California. A series of oral and poster presentations at the conference will showcase new clinical findings from the GUARDIAN Registries, in addition to independent clinical analyses, emphasizing the...

UCI Health Partner with Sierra Donor Services to Expand Kidney Transplant Opportunities Utilizing Paragonix KidneyVault Preservation Technology

WALTHAM, Mass.--(BUSINESS WIRE)--Paragonix Technologies, a pioneer in organ transplant technologies and organ procurement services, announced today a groundbreaking initiative with Sierra Donor Services and UCI Health to place high-risk donor kidneys, expanding transplant opportunities for patients in need. Sierra Donor Services, a nonprofit organ procurement organization (OPO) serving more than 2.8 million people across 13 counties in Northern California and Nevada, is leveraging this collabor...

Paragonix Technologies LIVERguard® Used in Cross-Country Donor Liver Transplant Case

WALTHAM, Mass.--(BUSINESS WIRE)--Paragonix Technologies, Inc., a leader in organ preservation technology, announces an exciting achievement for its Paragonix LIVERguard® System as the device safely preserved a donor liver during a recovery which covered the cross-country distance from the West Coast to North Carolina. This incredible journey resulted in a successful transplant at Duke University Hospital, one of the largest organ transplant centers in the world. The case marks one of the longes...
Back to Newsroom